Neural mechanisms mediating appetitive regulation and smoking in nicotine addiction Save

Date Added
April 16th, 2019
PRO Number
Pro00086509
Researcher
Brett Froeliger

List of Studies


Profiles_link
Keywords
Smoking
Summary

Nicotine addiction is a chronic, relapsing brain disorder and although it is the leading cause of preventable premature death in the US, ~20% of adults smoke and among those that try to quit, the majority relapse.Research suggest that nicotine addiction disrupts the working in the brain involved in motivation and reward. The overarching goal of this proposal is to utilize clinical neuroscience to investigate the effects of Mindfulness Oriented Recovery Enhancement (MORE) on modifying behavior to help treat nicotine addiction.

Institution
MUSC
Recruitment Contact
Katherine Lastrapes
8437927865
lastrape@musc.edu

Determining the impact of cannabis use and severity on tobacco outcomes: A prospective tobacco treatment trial Save

Date Added
April 6th, 2019
PRO Number
Pro00086954
Researcher
Erin Mcclure

List of Studies


Profiles_link
Keywords
Smoking, Substance Use
Summary

The purpose of this study is to evaluate the impact of concurrent cannabis use and severity on tobacco abstinence. All participants will receive tobacco cessation treatment (varenicline) for 12 weeks. This study will recruit adult tobacco users (ages 18-40) who are motivated to quit smoking cigarettes.

Institution
MUSC
Recruitment Contact
Patrick Cato
843-792-4097
smokingstudy@musc.edu

Mobile, remote, and individual-focused: Comparing breath carbon monoxide readings and abstinence in next generation monitors. Save

Date Added
March 8th, 2019
PRO Number
Pro00080107
Researcher
Erin Mcclure

List of Studies


Profiles_link
Keywords
Smoking
Summary

Breath carbon monoxide (CO) can be used as an indicator of recent smoking and is measured by CO monitors. Breath CO can also be used to determine abstinence from smoking. There are several breath CO monitors commercially available, including a next generation model that connects directly to a smartphone and interfaces with a mobile application. Given the importance of comparability between different CO monitors, this study involves a comparison between three monitors to assess their agreement in CO readings and detecting abstinence from smoking.

Institution
MUSC
Recruitment Contact
Patrick Cato
843-792-6152
catop@musc.edu

Development and Testing of an Electronic Visit for COPD Early Detection and Smoking Cessation Save

Date Added
March 5th, 2019
PRO Number
Pro00086016
Researcher
Jennifer Dahne

List of Studies

Silhouette
Keywords
Smoking
Summary

The goal of this work is to develop, refine, and pilot test an electronic visit (e-visit) to: 1) deliver smoking cessation treatment to adults at risk for COPD and 2) to improve rates of COPD early detection and accurate diagnosis. We will conduct a pilot RCT of the COPD/smoking cessation e-visit as compared to treatment as usual (TAU), with primary objective to provide effect size estimates for a larger RCT.

Institution
MUSC
Recruitment Contact
Noelle Natale
843-876-2441
natalen@musc.edu

Development and Evaluation of a Low Cost, Remote Method to Biochemically Verify Smoking Status Save

Date Added
February 5th, 2019
PRO Number
Pro00085109
Researcher
Jennifer Dahne

List of Studies

Silhouette
Keywords
Smoking
Summary

Although smoking cessation interventions are increasingly moving toward remote delivery, remote assessment of smoking behavior faces one key methodological limitation: the need for biochemical verification of smoking status. To address this need, we herein will develop a remote CO data capture system through which a smartphone-enabled CO monitor (iCO™ Smokerlyzer) is integrated with REDCap. Subsequently, we will conduct a remote feasibility trial with smokers to examine: a) validity of the remote iCO™/REDCap data capture system as compared to gold-standard methods for biochemical verification of smoking and b) compliance with remote CO monitoring via the iCO™/REDCap system as applied both to episodic (i.e., once per week) and granular (i.e., once per day) data collection.

Institution
MUSC
Recruitment Contact
Lisa Coles
843-876-2291
colesl@musc.edu

Effects of filter ventilation on sensory response, smoking topography, and inhalation (COMET 2 2.1) Save

Date Added
October 31st, 2018
PRO Number
Pro00082861
Researcher
Kenneth Cummings

List of Studies

Silhouette
Keywords
Smoking
Summary

The aim is to assess the link between marketing proxies for filter ventilation (product descriptors, packaging) and risk beliefs. Ventilation is not directly promoted to consumers; rather its effects are communicated through the use of descriptive terms such as Light, Mild, and Low tar, often linked to lighter colors. Since the key terms have been restricted and replaced with others, it is important to determine which factors continue to contribute to false relative risk beliefs. We will conduct semi-structured interviews common in marketing research to test the influence of pack
descriptors and colors (as proxies for filter ventilation) on product risk perceptions and intention
to purchase..

Institution
MUSC
Recruitment Contact
Katherine Lastrapes
843-882-7196
lastrape@musc.edu

Establishment of a Registry for Patients Treated with Photodynamic Therapy (PDT) Save

Date Added
October 18th, 2018
PRO Number
Pro00082282
Researcher
Gerard Silvestri

List of Studies


Profiles_link
Keywords
Cancer, Cancer/Lung, Stage I, Stage II, Stage III, Stage IV
Summary

Photodynamic therapy (PDT) is a type of treatment used to treat cancer. The purpose of this research study is to collect information on patients treated with PDT so that we can determine if patient characteristics affect their response to PDT. We will collect information about medical history, life style habits like smoking, reports from the tissue taken during biopsy, and outcome of the treatment to include in the registry.

Institution
MUSC
Recruitment Contact
Katherine Taylor
843-792-2297
taylkat@musc.edu

An fMRI pilot study of the effects of Clavulanic Acid on cigarette withdrawal Save

Date Added
September 18th, 2018
PRO Number
Pro00078213
Researcher
Brett Froeliger

List of Studies


Profiles_link
Keywords
Smoking
Summary

The broad objective of this proposal is to use fMRI methods to conduct preliminary investigation of the effects of Clavulanic Acid on neurocognition and smoking withdrawal in abstinent cigarette smokers. This project will involve collecting data from a total of approximately 40 adult smokers.

Institution
MUSC
Recruitment Contact
Shannon Powers
843-882-7196
powerssh@musc.edu

Impact of e-cigarette characteristics on reinforcement and tobacco use patterns among current smokers Save

Date Added
September 4th, 2018
PRO Number
Pro00081069
Researcher
Tracy Smith

List of Studies

Silhouette
Keywords
Smoking
Summary

The purpose of this project is to understand how different e-cigarettes influence their likeability and use among current smokers who try using e-cigarettes. Participants will receive an e-cigarette to sample over a three week period. During this time period they will complete daily electronic diaries and weekly lab visits. The results from this information will help us understand how different types of e-cigarettes are likely to influence cigarette and e-cigarette use.

Institution
MUSC
Recruitment Contact
Tracy Smith
8437925164
smithtra@musc.edu

A Pilot Translational Study of Varenicline Sampling to Promote Treatment Engagement and Smoking Cessation Save

Date Added
July 3rd, 2018
PRO Number
Pro00078289
Researcher
Matthew Carpenter

List of Studies


Profiles_link
Keywords
Smoking
Summary

This is a research study to find out if a smoking cessation medication, varenicline, is effective when given to smokers, remotely, as a one-time, 4-week sample.

Participants will either receive a sample of varenicline, or not. This will be decided randomly. The medicine will be mailed to participants and participants will complete 5 study contacts in addition to completing daily diaries for the first 4 weeks of the study. Participation will last 3 months.

Varenicline is a well-established medication that helps smokers quit. If participants are in the group that receives varenicline, it may help them too. But they are not required to use it, and it is completely up to them to use as they wish. Side effects from taking varenicline might include insomnia, headache, or nausea. Some individuals report negative changes in mood. Most smokers who use varenicline do not experience these symptoms.

Institution
MUSC
Recruitment Contact
Lisa Coles
843-876-2291
colesl@musc.edu

Change_preferences

-- OR --

Create_login